Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(11):794-796; doi:10.1093/jnci/97.11.794
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Christensen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Cancer Conference Aimed To Spur U.S.–Israeli Collaborations

Damaris Christensen

The first 10% of the full text of this article appears below.

Israel has historically been a strong center for cancer research; for example, the discovery of ubiquitin and the role of p53 in cancer are products of Israeli research. But concerns that the tense political situation in the region was leading to scientific isolation prompted a team of U.S. researchers to organize the first Joint American–Israeli Conference on Cancer, held in March in Jerusalem.

In the last 5 years, "Israel pretty much dropped off the map in terms of scientific conferences," said Joseph Rosenblatt, M.D., of the University of Miami Sylvester Comprehensive Cancer Center, one of three co-organizers of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?